Metraipolis › archive › dc_d5ea7134a667

Biomimetic delivery of a STING agonist via tumor antigen-primed dendritic cell membrane nanovesicles for bladder cancer immunotherapy — Europe PMC PMID:42388376

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42388376
DOI
10.1016/j.mtbio.2026.103333
License (as archived)
solo-consultazione
Archived
2026-10-31T14:19:40.383Z
SHA-256 of the archived text
6bfcbcfce37c188196fb80d817a5d35cd4741efbebaf72f16ab2ed3baa8dbf8f
Stable URL of this page
https://metraipolis.com/documento/dc_d5ea7134a667

How to cite

Biomimetic delivery of a STING agonist via tumor antigen-primed dendritic cell membrane nanovesicles for bladder cancer immunotherapy — Europe PMC PMID:42388376 — Europe PMC (en), https://europepmc.org/article/MED/42388376 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d5ea7134a667 (Metraipolis archive dc_d5ea7134a667, sha256 6bfcbcfce37c188196fb80d817a5d35cd4741efbebaf72f16ab2ed3baa8dbf8f)
BibTeX
@misc{dcd5ea7134a667,
  title = {Biomimetic delivery of a STING agonist via tumor antigen-primed dendritic cell membrane nanovesicles for bladder cancer immunotherapy — Europe PMC PMID:42388376},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42388376},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d5ea7134a667; sha256 6bfcbcfce37c188196fb80d817a5d35cd4741efbebaf72f16ab2ed3baa8dbf8f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42388376. Agents can read the archived copy with the MCP tool read_document.